About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
1,276
By Phase
PHASE2: 2
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06927739Lead Sponsor
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
PHASE2Recruiting
240 participants
Started: Aug 11, 2025 · Completed: Jun 1, 2027
NCT04946461Collaborator
The Day-time Response Variation of (Lis)Dexamphetamine
N/ACompleted
16 participants
Started: Jul 1, 2021 · Completed: Jun 16, 2022
NCT04776629Lead Sponsor
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
PHASE2Completed
77 participants
Started: Jun 30, 2021 · Completed: Nov 11, 2022
NCT04868435Collaborator
Triggers for Post-Viral Parosmia
N/ACompleted
943 participants
Started: Nov 3, 2020 · Completed: Feb 3, 2023
Locations (1)
Headquarters
Los Angeles, CA, United States
Map
Loading map...